Carbon dioxide (CO2) is the predominant gas molecule emitted during aerobic respiration. Although CO2 can improve blood circulation in the skin via its vasodilatory effects, its effects on skin inflammation remain unclear. The present study aimed to examine the anti-inflammatory effects of CO2 in human keratinocytes and skin. Keratinocytes were cultured under 15% CO2, irradiated with ultraviolet B (UVB), and their inflammatory cytokine production was analyzed. Using multiphoton laser microscopy, the effect of CO2 on pH was observed by loading a three-dimensional (3D)-cultured epidermis with a high-CO2 concentration formulation. Finally, the effect of CO2 on UVB-induced erythema was confirmed. CO2 suppressed the UVB-induced production of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) in keratinocytes and the 3D epidermis. Correcting medium acidification with NaOH inhibited the CO2-induced suppression of TNFα and IL-6 expression in keratinocytes. Moreover, the knockdown of H+-sensing G protein-coupled receptor 65 inhibited the CO2-induced suppression of inflammatory cytokine expression and NF-κB activation and reduced CO2-induced cyclic adenosine monophosphate production. Furthermore, the high-CO2 concentration formulation suppressed UVB-induced erythema in human skin. Hence, CO2 suppresses skin inflammation and can be employed as a potential therapeutic agent in restoring skin immune homeostasis.
The skin is the largest organ of the human body. It acts as a protective covering while serving as a barrier separating the body from the external environment. The stratum corneum and tight junctions in the granular layers prevent the entry of external stimuli such as antigens, microorganisms, and ultraviolet (UV) radiation from the external environment, as well as water evaporation from the internal environment1. When antigens and pathogens enter the skin through these physical barriers, resident/infiltrated immune cells induce an immune response to eliminate them. Epidermal keratinocytes, which are responsible for building a physical barrier, play an important role in skin immunity and cooperate with immune cells by producing various growth factors, cytokines, and chemokines in response to external stimuli2. In addition, UV radiation from sunlight is a major stress source for keratinocytes and affects various biological functions including the nervous system and endocrine system through the skin3. UV-induced oxidative stress leads to mitochondrial dysfunction and activation of the nuclear factor kappa B (NF-κB) pathway, a major inflammatory response pathway, resulting in cell death4,5,6. On the other hand, there are multiple UV-responsive stress proteins in keratinocytes, such as the NF-E2 related factor (NRF) family, which play a role in suppressing oxidative stress to prevent excessive cell death7,8,9. Consequently, the skin functions as an immunological organ; however, excessive immune responses can lead to chronic skin inflammation and further to inflammatory skin diseases such as atopic dermatitis and psoriasis10. These diseases are difficult to cure and are accompanied by physical and mental stress due to skin symptoms that significantly reduce the quality of life, such as pruritus, redness, and lichenification. Therefore, the daily prevention of excessive immune responses is vital for maintaining skin immune homeostasis.
Carbon dioxide (CO2) is one of the principal gas molecules responsible for aerobic respiration. In the cell, CO2, a by-product of oxidative metabolism in the tricarboxylic acid (TCA) cycle, passively diffuses through the body and is expelled via the lungs by red blood cells. In mammals, neurons in the brainstem and the peripheral carotid body detect blood CO2 pressure, usually maintained at approximately 40 mmHg11. This CO2-sensing system also exists in flies and nematodes12,13, implying that CO2 homeostasis is critical for the survival of various species.
Some gas molecules have been shown to function as signaling mediators called ‘gasotransmitters’14. Among them, hydrogen sulfide and nitric monoxide are well-known and are involved in physiological functions in the skin, such as vasodilation, cell proliferation, apoptosis, and inflammation15,16. These facts suggest that gasotransmitters play an important role in maintaining skin homeostasis. Recent studies have reported that CO2 improves alveolar damage in rat models and patients with acute respiratory distress syndrome17,18,19. In addition, CO2 has been shown to suppress lipopolysaccharide (LPS)-induced inflammatory responses in several blood cell types and lung-derived cell lines20,21,22. Consequently, this points to CO2 not only as a by-product of aerobic respiration but also to its role as a gasotransmitter in suppressing inflammatory responses. In the skin, CO2 has been shown to improve wound healing and seasonal barrier dysfunction23,24,25; inflammation is known to be strongly involved in skin wound healing and barrier functions as well as the circulatory system. The wound-healing process consists of three phases: the inflammatory phase, proliferative phase, and stable phase; this process may be delayed when an excessive inflammatory response is triggered during the inflammatory phase26. Various cytokines secreted from keratinocytes, fibroblasts, and inflammatory cells are critical factors that influence skin barrier function and keratinocyte differentiation27; however, little is known about the relationship between CO2 and skin inflammation.
In the present study, the anti-inflammatory mechanism of CO2 was elucidated using a UVB-irradiated human keratinocyte model, focusing on the CO2-induced decrease in extracellular pH. In addition, the effect of CO2 on UV-induced erythema was evaluated in human skin.
CO2 inhibited UVB-induced cytokine expression in HEKn and the 3D epidermis
Human epidermal keratinocytes isolated from neonatal foreskin (HEKn) cultured in 15% CO2 displayed a significantly lower UVB-induced increase in TNFα and IL-6 mRNA expression (Fig. 1a,b) alongside significantly lower TNFα and IL-6 protein levels in the culture supernatant (Fig. 1c,d). In addition, the 3D epidermis treated with the high-CO2 concentration formulation (CO2) displayed a significantly lower UVB-induced increase in TNFα and IL-6 mRNA expression than the 3D epidermis treated with the control (Ctl) formulation (Fig. 1e,f). Taken together, these data indicate that CO2 suppresses the production of UVB-induced inflammatory cytokines in the epidermis.
CO2 induced extracellular acidification, which produced anti-inflammatory effects
pH changes in the 3D epidermis were visualized using the pH-dependent fluorescent indicators, BCECF and BCECF-AM. BCECF can selectively visualize extracellular pH due to its membrane impermeability, whereas BCECF-AM can selectively visualize intracellular pH as it is hydrolyzed into membrane-impermeable BCECF by cytosolic esterase. In this study, we found that extracellular BCECF-derived fluorescence was attenuated when the high-CO2 concentration formulation was applied to the surface of the 3D epidermis (Fig. 2a) and the extracellular BCECF-derived representative FT decreased significantly, suggesting that CO2 administration caused extracellular acidification (Fig. 2b). In the HEKn, UVB-induced increases in TNFα and IL-6 mRNA expression were significantly suppressed depending on the acidification of the culture medium (Fig. 2c,d). Moreover, when the pH of the culture medium was neutralized using NaOH under 15% CO2 condition, the CO2-induced suppression of TNFα and IL-6 mRNA expression was reduced (Fig. 2e,f). Thus, these results indicate that CO2-induced extracellular acidification may suppress UVB-induced inflammatory cytokine expression.
CO2-activated GPR65 signaling suppressed UVB-induced inflammation by inhibiting NF-κB activation in HEKn
Extracellular pH changes are detected by H+-sensing GPCRs28. It was determined that GPR65 mRNA was highly expressed in HEKn compared to other H+-sensing GPCRs (Fig. 3a). Therefore, GPR65 was knocked down in HEKn using GPR65-specific siRNA to clarify its role in CO2-induced anti-inflammatory effects (Fig. 3b). GPR65 knockdown significantly inhibited the CO2-induced downregulation of TNFα and IL-6 mRNA expression (Fig. 3c,d); furthermore, it diminished the CO2-induced suppression of inhibitor-κBα (I-κBα) degradation and p65 nuclear translocation caused by UVB irradiation (Fig. 3e,f). However, no difference was observed in the UVB-induced phosphorylation of p38, extracellular signal-regulated 1/2 (ERK1/2), or c-Jun N-terminal kinase (JNK) following 15% CO2 incubation or GPR65 knockdown (Fig. 3g). Culture under 15% CO2 significantly increased the intracellular cAMP concentration; however, this CO2-induced increase was diminished by GPR65 knockdown (Fig. 3h). Moreover, when dibutyryl cAMP, a cAMP analog, was added to clarify the anti-inflammatory effect of cAMP in HEKn, UVB-induced TNFα and IL-6 mRNA expressions were significantly suppressed in a concentration-dependent manner (Fig. 3i,j). Taken together, these results indicate that CO2-induced extracellular acidification activates GPR65, increases intracellular cAMP concentration, and inhibits UVB-induced NF-κB activation.
CO2 inhibited UVB-induced erythema in human skin
To clarify the anti-inflammatory effects of CO2 on human skin, control and high-CO2 concentration formulations were applied to the skin on the inner upper arm of nine men, followed by UVB irradiation. UVB-induced skin erythema formation and MED were suppressed in the skin area where CO2 had been applied (Fig. 4a,b). In addition, the Δa* value (obtained by subtracting the a* value of the non-irradiated site from that of the site irradiated with 1MED UVB) was significantly lower in the skin area where CO2 had been applied (Fig. 4c). Thus, these results indicate that CO2 may exert anti-inflammatory effects in human skin.
UV radiation emitted from the sun induces skin inflammation, which causes a wide range of skin symptoms from spots and wrinkles to dermatitis and skin cancer. In the present study, the anti-inflammatory effects of CO2 were examined using a UVB-induced inflammation model. It was found that CO2 suppressed TNFα and IL-6 production in human keratinocytes and the 3D epidermis and attenuated UVB-induced erythema formation in human skin. Since inflammatory cytokines such as TNFα and IL-6 are known to play key roles in skin inflammation29,30, CO2 may reduce UV-induced inflammation by suppressing their production.
The percutaneous administration of CO2 has been shown to increase blood flow in the skin by reducing vascular smooth muscle tension under the epidermis31,32, signifying that CO2 has relatively high transdermal permeability. Therefore, CO2 may permeate through the stratum corneum and react with H2O in the interstitial fluid to produce H+, resulting in mild extracellular acidification. Consequently, the role of extracellular pH in the anti-inflammatory effects of CO2 was investigated. In keratinocytes, the CO2-induced suppression of TNFα and IL-6 expression was dependent on the pH of the culture medium, indicating that extracellular pH exerts important effects on skin inflammation. Interestingly, it has been reported that UV irradiation induces intracellular pH reduction and cell death in keratinocytes33. These findings suggest that intracellular and extracellular pH changes exert different physiological effects. In the skin, the pH of the stratum corneum is known to play an important role in various pathological conditions. It is usually maintained in an acidic range of 4.1–5.8; however, it registers an increase in inflammatory skin diseases34. Previous studies have shown that the disturbance of pH homeostasis disrupts various skin functions such as the antimicrobial response, skin barrier action, and inflammation35,36,37. Thus, the topical application of CO2 may improve the barrier and antimicrobial functions of the stratum corneum and suppress excessive inflammatory responses in the epidermis via CO2-induced acidification.
Cells detect extracellular pH via acid-sensing ion channels and H+-sensing GPCRs28,38. Although Na+/H+ exchanger 1 (NHE1) has been reported to sense extracellular pH changes in the skin39,40, the biological sensors linking pH changes to skin inflammatory responses have not yet been elucidated. In the present study, it was demonstrated for the first time that GPR65, an H+-sensing GPCR, may detect CO2-induced extracellular acidification and exert anti-inflammatory effects in keratinocytes. GPR65 has been reported to act as a psychosine receptor41; however, it has also been found to act as an H+ sensor42,43,44, whose activation induces cAMP production via Gαs signaling. In the present study, GPR65 knockdown in keratinocytes suppressed CO2-induced cAMP production, while dibutyryl cAMP, a cAMP analog, inhibited TNFα and IL-6 expressions. These results indicate that CO2-induced GPR65/cAMP signaling plays an important role in suppressing inflammation. There are various types of Gα subunits (Gαs, Gαi, Gαq, and Gα12), each transmitting different cellular signals45; however, it remains unclear whether GPR65 activates other Gα proteins.
UV irradiation is known to induce inflammatory responses by MAPK and NF-κB46. In this study, CO2 did not affect the phosphorylation of p38, ERK1/2, or JNK, implying that CO2 does not exert its anti-inflammatory effects via the MAPK pathway. However, CO2 did suppress UVB-induced I-κBα degradation and p65 nuclear translocation, while GPR65 knockdown opposed the CO2-induced suppression of NF-κB activation. Based on these results, it was hypothesized that CO2 exerts its anti-inflammatory effects by activating GPR65 and following suppression of the NF-κB pathway. While this finding is partly consistent with a previous work by Cummins et al.47, other studies have shown that CO2 does not affect I-κBα degradation in LPS-sensitized THP-1 cells and macrophages22. These conflicting results may be due to different NF-κB activation mechanisms since it was recently reported that there is a third UV-dependent NF-κB activation pathway in addition to the canonical and non-canonical pathways48. In this pathway, I-κBα is translocated into the nucleus by UV irradiation without phosphorylation, where it is degraded by forming a complex with β-Transducin repeat Containing Protein (β-TrCP), a subunit of the ubiquitin-protein ligase complex, using IKKβ as a scaffold. Therefore, GPR65 activation may affect this UV-dependent NF-κB pathway; however, further studies are required to elucidate the detailed mechanism.
Skin inflammation is strongly involved in the pathogenesis of inflammatory skin diseases49. Indeed, previous studies have shown that the inhibition of phosphodiesterase 4 (PDE4), a cAMP-degrading enzyme, improves atopic dermatitis and psoriasis50,51; consequently, certain PDE4 inhibitors have been approved to treat these diseases52,53. These clinical results suggest that cAMP plays a key role in the pathogenesis of inflammatory skin diseases. Since CO2 has been shown to promote cAMP production in keratinocytes, it may exert a similar, albeit mild, effect as PDE4 inhibitors. Thus, the topical application of CO2 may serve as a novel therapeutic approach for treating patients with inflammatory skin disorders.
In conclusion, in the present study, it was demonstrated that CO2 activates GPR65 via extracellular acidification and exerts anti-inflammatory effects by suppressing NF-κB activation in keratinocytes. Moreover, the topical application of a high-CO2 concentration formulation inhibited UVB-induced erythema formation, implying that CO2 suppresses skin inflammation in vivo. Therefore, our hypothesis, derived from the obtained results, states that CO2 is a unique gas molecule that can suppress skin inflammation.
High-CO2 concentration formulation
The formulations used in the present study were prepared as described previously25. The high-CO2 concentration and control formulations used the same base composition; however, the high-CO2 concentration formulation contained ~ 1500–2000 ppm of CO2 in the form of microbubbles.
HEKn (Invitrogen, Carlsbad, CA, USA) isolated from the foreskin of neonatal Caucasian subjects was cultured in EpiLife medium (Gibco, Waltham, MA, USA) supplemented with additive agents (HuMedia-KG kit; KURABO, Osaka, Japan). Before the experiments, the culture medium was replaced with fresh medium without additive agents. For the high-CO2 experiments, cells were cultured in a humidified incubator under 15% CO2 for 24 h. For the low-pH experiments, cells were cultured in a pH-modified culture medium for 24 h, with 1 M HCl and 1 M NaOH used to adjust the pH of the culture medium. For dibutyryl cAMP (dbcAMP; Sigma-Aldrich, St. Louis, MO, USA) treatment, cells were incubated with 0.1, 0.2, and 0.5 mM of dbcAMP for 24 h.
A three-dimensional (3D) epidermis (LabCyte EPI-MODEL 12; Japan Tissue Engineering Co. Ltd, Aichi, Japan) was cultured and maintained according to the manufacturer's instructions. For the high-CO2 experiments, high-CO2 concentration and control formulations were applied to the surface of the 3D epidermis for 12 h. Next, the cells and 3D epidermis were washed with Dulbecco’s phosphate buffered saline (DPBS; Gibco) and exposed to 20 mJ/cm2 UVB using a BIO-UV EXPOSURE instrument (SEN LIGHTS Co. Ltd, Osaka, Japan).
Intra-epidermal pH imaging
For intra-epidermal pH imaging, multiphoton laser microscopy (DermaInspect; JenLab, Jena, Germany) was applied. Since the fluorescence lifetime (FT) of 2′,7′-bis(carboxyethyl)-4 or 5-carboxyfluorescein (BCECF) has been shown to correlate with pH54, the FT was used as an indicator of intra-epidermal pH. The culture medium of the 3D epidermis was replaced with Hanks’ balanced salt solution (HBSS; Gibco) supplemented with BCECF or BCECF-AM (DOJINDO, Kumamoto, Japan) at a final concentration of 10 μM. After 15 min, the 3D epidermis was washed with HBSS solution and used for pH imaging, whereby 3–5 mW of laser light was focused on to the epidermis from 10 μm above the insert membrane. Fluorescent images were acquired inside the epidermis and analyzed using SPC Image 2.9.4 (Becker & Hickl GmbH, Berlin, Germany). A bi-exponential fit was used on the fluorescence decay profiles, and the FT was determined for each pixel, with the largest value recorded as the representative FT of the image.
G protein-coupled receptor (GPCR) expression measurement
To measure GPCR expression, HEKn were grown to 50% confluence and collected for RNA extraction. Digital PCR was performed on a QuantStudio 3D Digital PCR System platform consisting of a ProFlex PCR machine (including a chip adapter kit), an automatic chip loader, and a QuantStudio 3D Instrument (Life Technologies, Carlsbad, CA, USA). Specific TaqMan probes for digital PCR (Supplementary Table 1; see Supplementary Information) were selected from the TaqMan Gene Expression Assay (Applied Biosystems, Foster City, CA, USA).
HEKn were grown to 50% confluence and transfected with specific siRNA against GPR65 or control non-target siRNA (Dharmacon, Lafayette, CO, USA) using Lipofectamine RNAiMAX transfection reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. After 48 h, the cells were used for the high-CO2 experiments.
HEKn transfected with siRNA for 48 h were incubated under 15% CO2 for 24 h in the presence of the phosphodiesterase inhibitor 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich, St. Louis, MO, USA) and then collected. Intracellular cAMP concentration was measured using a cAMP-Glo Assay (Promega, Madison, WI, USA) according to the manufacturer’s instructions.
RNA isolation and qRT-PCR
HEKn and the 3D epidermis were collected 8 h after UVB exposure. Total RNA was isolated using an RNeasy Mini Kit (Qiagen, Hilden, Germany) reverse-transcribed into cDNA using a High Capacity RNA-to-cDNA Kit (Applied Biosystems). Quantitative real-time PCR (qRT-PCR) was performed using a TaqMan Gene Expression Assay (Applied Biosystems) with specific probes for each target gene (Supplementary Table 2; see Supplementary Information). Results were normalized to RPLP0.
Enzyme-linked immunosorbent assay (ELISA)
TNFα and IL-6 concentrations in the culture media of HEKn were measured using cytokine ELISA kits (Diaclone, Besancon, France) according to the manufacturer’s instructions. Absorbance was measured using an SH-9000 Lab microplate reader (Corona Electric, Ibaragi, Japan).
For whole-cell protein extraction, HEKn were treated with radio-immunoprecipitation assay (RIPA) lysis buffer (Thermo Fisher Scientific, San Jose, CA, USA) supplemented with a protease/phosphatase inhibitor cocktail (Cell Signaling Technology, Beverly, MA, USA). For nuclear and cytoplasmic extraction, a nuclear extraction kit (Active Motif, Carlsbad, CA, USA) was used according to the manufacturer’s instructions. Protein was quantified in each lysate using a BCA protein assay kit (Thermo Fisher Scientific), and lysates containing equal amounts of proteins were loaded onto Mini-PROTEAN TGX gels (Bio-Rad, Hercules, CA, USA), electrophoresed, and transferred to 0.2-μm polyvinylidene fluoride (PVDF) membranes using a Trans-Blot Turbo System (Bio-Rad). The membranes were blocked with PVDF Blocking Reagent (TOYOBO, Osaka, Japan) and incubated with primary and horseradish peroxidase (HRP)-conjugated secondary antibodies (Supplementary Table 3; see Supplementary Information). Bound antibodies were detected using ECL Prime Western Blotting Detection Reagent (GE Healthcare, Arlington Heights, IL, USA).
The present study was approved by the Ethical Committee of Kao Corporation and conducted in accordance with the study protocol, ethical guidelines for clinical research, and ethical principles based on the Helsinki Declaration; it was registered with the UMIN Clinical Trials Registration System and is publicly available (# UMIN000019152). All study participants were informed regarding the content matter of the present study, and they provided informed consent. A total of nine healthy Japanese men between 20 and 50 years were recruited for this double-blind, placebo-controlled study. High-CO2 and control formulations were applied to a designated area (5 × 15 cm) on the inside of the left upper arm twice daily (morning and night). After 2 weeks, each site was irradiated with 10, 20, 30, 40, 50, 60, or 70 mJ/cm2 of UVB (light source: UV-B lamp, GL20SE; Sankyo Denki, Kanagawa, Japan). The following day, minimal erythema dose (MED) was judged, and color was measured using a spectrocolorimeter to confirm erythema formation. The *a value of the L*a*b* colorimetric system was used as an index of erythema.
Data are presented as the mean ± SEM. For the experiments using HEKn and 3D epidermis, between-group differences were analyzed by the unpaired Student’s t tests, Dunnett’s test, or Tukey–Kramer multiple comparison tests, as appropriate. For the human study, between-group differences were analyzed by the paired Student’s t tests.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Rawlings, A. V. & Harding, C. R. Moisturization and skin barrier function. Dermatol. Ther. 17(Suppl 1), 43–48 (2004).
Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M. & Nickoloff, B. J. Keratinocytes as initiators of inflammation. Lancet 337, 211–214 (1991).
Slominski, A. T., Zmijewski, M. A., Plonka, P. M., Szaflarski, J. P. & Paus, R. How UV light touches the brain and endocrine system through skin, and why. Endocrinology 159, 1992–2007 (2018).
Kim, Y. & He, Y. Y. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis. 1, 188–198 (2014).
Paz, M. L., González Maglio, D. H., Weill, F. S., Bustamante, J. & Leoni, J. Mitochondrial dysfunction and cellular stress progression after ultraviolet B irradiation in human keratinocytes. Photodermatol. Photoimmunol. Photomed. 24, 115–122 (2008).
Kleszczyński, K. et al. Melatonin and its metabolites ameliorate UVR-induced mitochondrial oxidative stress in human MNT-1 melanoma cells. Int. J. Mol. Sci. 19, 3786 (2018).
Marais, T. L. D. et al. Transcription factors and stress response gene alterations in human keratinocytes following solar simulated ultra violet radiation. Sci. Rep. 7, 13622 (2017).
Gęgotek, A. & Skrzydlewska, E. The role of transcription factor Nrf2 in skin cells metabolism. Arch. Dermatol. Res. 307, 385–396 (2015).
Janjetovic, Z. et al. Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. Sci. Rep. 7, 1274 (2017).
Griffiths, C. E. M., van de Kerkhof, P. & Czarnecka-Operacz, M. Psoriasis and atopic dermatitis. Dermatol. Ther. (Heidelb). 7(Suppl 1), 31–41 (2017).
Cummins, E. P., Selfridge, A. C., Sporn, P. H., Sznajder, J. I. & Taylor, C. T. Carbon dioxide-sensing in organisms and its implications for human disease. Cell. Mol. Life Sci. 71, 831–845 (2014).
Chandrashekar, J. et al. The taste of carbonation. Science 326, 443–445 (2009).
Frommer, W. B. CO2mmon sense. Science 327, 275–276 (2010).
Papapetropoulos, A., Foresti, R. & Ferdinandy, P. Pharmacology of the “gasotransmitters” NO, CO and H2S: Translational opportunities. Br. J. Pharmacol. 172, 1395–1396 (2015).
Cals-Grierson, M. M. & Ormerod, A. D. Nitric oxide function in the skin. Nitric Oxide 10, 179–193 (2004).
Coavoy-Sánchez, S. A., Costa, S. K. P. & Muscará, M. N. Hydrogen sulfide and dermatological diseases. Br. J. Pharmacol. 177, 857–865 (2020).
Amato, M. B. et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N. Engl. J. Med. 338, 347–354 (1998).
Laffey, J. G. et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 169, 46–56 (2004).
Costello, J. et al. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit. Care Med. 37, 2412–2420 (2009).
Takeshita, K. et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-[kappa]B activation. Am. J. Respir. Cell Mol. Biol. 29, 124–132 (2003).
O’Toole, D. et al. Hypercapnic acidosis attenuates pulmonary epithelial wound repair by an NF-kappaB dependent mechanism. Thorax 64, 976–982 (2009).
Wang, N. et al. Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage. FASEB J. 24, 2178–2190 (2010).
Brandi, C. et al. The role of carbon dioxide therapy in the treatment of chronic wounds. In Vivo 24, 223–226 (2010).
Penhavel, M. V. C., Nascimento, V. H. T., Durães, E. F. R., Carneiro, F. P. & de Sousa, J. B. Effects of carbon dioxide therapy on the healing of acute skin wounds induced on the back of rats. Acta Cir. Bras. 28, 334–339 (2013).
Yuki, K., Kawano, S., Mori, S. & Murase, T. Facial application of high-concentration carbon dioxide prevents epidermal impairment associated with environmental changes. Clin. Cosmet. Investig. Dermatol. 12, 63–69 (2019).
Sindrilaru, A. et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Investig. 121, 985–997 (2011).
Hänel, K. H., Cornelissen, C., Lüscher, B. & Baron, J. M. Cytokines and the skin barrier. Int. J. Mol. Sci. 14, 6720–6745 (2013).
Okajima, F. Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cell Signal. 25, 2263–2271 (2013).
Geiger, T. et al. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18, 717–721 (1988).
Kondo, S. & Sauder, D. N. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Eur. J. Immunol. 27, 1713–1718 (1997).
Ito, T., Moore, J. I. & Koss, M. C. Topical application of CO2 increases skin blood flow. J. Investig. Dermatol. 93, 259–262 (1989).
Duling, B. R. Changes in microvascular diameter and oxygen tension induced by carbon dioxide. Circ. Res. 32, 370–376 (1973).
Kleszczyński, K., Tukaj, S., Kruse, N., Zillikens, D. & Fischer, T. W. Melatonin prevents ultraviolet radiation-induced alterations in plasma membrane potential and intracellular pH in human keratinocytes. J. Pineal Res. 54, 89–99 (2013).
Proksch, E. pH in nature, humans and skin. J. Dermatol. 45, 1044–1052 (2018).
Jang, H. et al. Skin pH is the master switch of kallikrein 5-mediated skin barrier destruction in a murine atopic dermatitis model. J. Investig. Dermatol. 136, 127–135 (2016).
Lee, H. J. et al. Acidification of stratum corneum prevents the progression from atopic dermatitis to respiratory allergy. Exp. Dermatol. 26, 66–72 (2017).
Lee, N. R. et al. Application of topical acids improves atopic dermatitis in murine model by enhancement of skin barrier functions regardless of the origin of acids. Ann. Dermatol. 28, 690–696 (2016).
Wemmie, J. A., Price, M. P. & Welsh, M. J. Acid-sensing ion channels: Advances, questions and therapeutic opportunities. Trends Neurosci. 29, 578–586 (2006).
Behne, M. J. et al. NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J. Biol. Chem. 277, 47399–47406 (2002).
Hachem, J. P. et al. Extracellular pH controls NHE1 expression in epidermis and keratinocytes: Implications for barrier repair. J. Investig. Dermatol. 125, 790–797 (2005).
Im, D. S., Heise, C. E., Nguyen, T., O’Dowd, B. F. & Lynch, K. R. Identification of a molecular target of psychosine and its role in globoid cell formation. J. Cell Biol. 153, 429–434 (2001).
Wang, J. Q. et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J. Biol. Chem. 279, 45626–45633 (2004).
Ishii, S., Kihara, Y. & Shimizu, T. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 280, 9083–9087 (2005).
Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L. & Witte, O. L. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl. Acad. Sci. U.S.A. 102, 1632–1637 (2005).
Dorsam, R. T. & Gutkind, J. S. G-protein-coupled receptors and cancer. Nat. Rev. Cancer 7, 79–94 (2007).
Assefa, Z., Van Laethem, A., Garmyn, M. & Agostinis, P. Ultraviolet radiation-induced apoptosis in keratinocytes: On the role of cytosolic factors. Biochim. Biophys. Acta 1755, 90–106 (2005).
Cummins, E. P. et al. NF-κB links CO2 sensing to innate immunity and inflammation in mammalian cells. J. Immunol. 185, 4439–4445 (2010).
Tsuchiya, Y. et al. Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation. Mol. Cell 39, 570–582 (2010).
Pasparakis, M., Haase, I. & Nestle, F. O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 14, 289–301 (2014).
Schafer, P. H. et al. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br. J. Pharmacol. 159, 842–855 (2010).
Andoh, T., Yoshida, T. & Kuraishi, Y. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis. Exp. Dermatol. 23, 359–361 (2014).
Keating, G. M. Apremilast: A review in psoriasis and psoriatic arthritis. Drugs 77, 459–472 (2017).
Hoy, S. M. Crisaborole ointment 2%: A review in mild to moderate atopic dermatitis. Am. J. Clin. Dermatol. 18, 837–843 (2017).
Hanson, K. M. et al. Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys. J. 83, 1682–1690 (2002).
We would like to thank Chiaki Sone and Masaru Hosokawa for providing the test samples at Skin Care Laboratories, Kao Corporation. We would also like to thank Editage for editing and reviewing this manuscript for the English language.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sayama, K., Yuki, K., Sugata, K. et al. Carbon dioxide inhibits UVB-induced inflammatory response by activating the proton-sensing receptor, GPR65, in human keratinocytes. Sci Rep 11, 379 (2021). https://doi.org/10.1038/s41598-020-79519-0